Mobile Menu - OpenMobile Menu - Closed

Text Size: A A A

News

Sep 22, 2016
[created_2]
[created_1]

Lawmakers rake Mylan CEO Bresch over hot coals over EpiPen price hikes

In The News |

Rep. DesJarlais on Wednesday blasted Mylan NV Chief Executive Heather Bresch for sharply increasing prices for the EpiPen emergency allergy treatment at a congressional hearing in which Republicans and Democrats questioned the reasons behind rising U.S. drug costs.

Sep 22, 2016
[created_2]
[created_1]

Mylan CEO blames rising cost of the EpiPen on 'opaque' industry pricing

In The News |

Rep. DesJarlais was quoted, “Do you have a guilty conscience about any of this?” In her testimony, Bresch tried to defend her pricing of the device that delivers an antidote to potentially deadly allergic reactions.

Sep 22, 2016
[created_2]
[created_1]

'YOU ASKED FOR IT' — Congress railed on the maker of EpiPen

In The News |

Under Rep. DesJarlais’ line of questioning along with the lack of transparency that exists in the drug-pricing market, Mylan's finances and figures did not add up under scrutiny. 

Sep 22, 2016
[created_2]
[created_1]

CEO of EpiPen maker defends pricing before Congress

In The News |

The price for a two-pack of EpiPens has increased more than 500 percent in the last decade, rising from $100 to more than $600.

Sep 22, 2016
[created_2]
[created_1]

Mylan chief insists EpiPen is priced fairly at House hearing

In The News |

Rep. DesJarlais along with other lawmakers chastised Mylan for amassing an $18 million salary, as she evaded questions on how much profit the pharmaceutical company made off EpiPen.

Sep 22, 2016
[created_2]
[created_1]

Mylan CEO grilled on Capitol Hill

In The News |

Rep. DesJarlais noted the generic’s price is still three times higher than EpiPen’s price was in 2007. “You’re trying to make us feel good,” he said. “And I’m not buying it.”

Sep 22, 2016
[created_2]
[created_1]

Documents reveal expected revenue from EpiPen sales after controversial price hike

In The News |

Rep. DesJarlais criticized Mylan for sharply increasing prices for the EpiPen and questioned the reasons behind rising U.S. drug costs. “Why’d you lower it by half if you thought it was fair? If you thought it was fair, leave it where it’s at?” 

Sep 21, 2016
[created_2]
[created_1]

Only 37 Republicans back plan to defund Muslim 'refugees'

In The News |

Rep. DesJarlais signed a letter calling for language to be inserted into an upcoming budget resolution that would cut funding for U.N. refugees coming to America from countries with active jihadist movements.
 

Sep 12, 2016
[created_2]
[created_1]

DesJarlais Commemorates 15 Year Anniversary of September 11th Attacks

Press Release |

Rep. DesJarlais Statement on September 11th

Washington, DC- Representative Scott DesJarlais, M.D. (TN-04) made the following statement marking the 15th anniversary of the September 11th, 2001 terror attacks.

Sep 7, 2016
[created_2]
[created_1]

Back on the Hill, GOP Lawmakers Take Aim at Iran ‘Ransom’ Payments

In The News |

Rep. DesJarlais among other members of the House Foreign Affairs Committee introduced legislation designed to tie administrations’ hands in future dealings with the Iran.

Pages